CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 455 shares at $16.59 ($7,548)
- 4 Planned sale SVP, GC & Corporate Secretary sold 825 shares at $16.59 ($13,687)
- 4 Planned sale Senior Vice President, R&D sold 825 shares at $16.59 ($13,687)
- 4 Planned sale SVP, Chief Accounting Officer sold 558 shares at an average $16.49 ($9,200)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Financial Officer sold 47 shares at $21.49 ($1,010)
- 8-K Event Auditor change
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
Page 22 of 65 · 1,286 filings